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DALYs: the age-weights on balance
J.J. Barendregt,1 L. Bonneux,2 & P.J. Van der Maas3
In studies for the 1993 World development report: investing in health Murray et al. developed the disability-
adjusted life year (DALY). This article examines one particular aspect of the DALY methodology: the
weighting of life years by age. For the quantitative implementation of this notion Murray proposed a general
equation to weight life years by age, which specifies that the years lived between the ages of 9 and 54 years
have a weight greater than unity, and for the years outside this range less than unity. The age-weighted life
years are used to calculate the "expected years of life lost" (EYLL). Comparison of age-weighted and
unweighted age-specific life expectancies shows that the age range which becomes more important due to
weighting is not 9-54 years, but 0-27 years. This happens because the EYLL is an age-weighting system
in itself, emphasizing the young. The result of piling one age-weighting system on top of the other gives an
even stronger emphasis on the young than the EYLL generates by itself. Although this is unlikely to upset
the results from the Global Burden of Disease study, we do not think it is desirable. And it is certainly different
from what we were led to expect.
Introduction
In 1994, Murray et al. published a series of articles in
the Bulletin of the World Health Organization (1-8)
on the global burden of disease and on health expen-
ditures and intervention packages, which describe
the basic studies carried out for the World develop-
ment report 1993: Investing in health (9). These arti-
cles, now also available in book format (10), give an
overview of the methodology used to assess the glo-
bal cost-effectiveness of specific health expenditure
packages. The sheer size of the undertaking com-
mands respect. This respect increases considerably
when examination of the Bulletin papers and back-
ground material (11) reveals the care with which this
study was carried out.
The study developed and applied several inno-
vative concepts, one of which - the disability-
adjusted life year (DALY) - has attracted much
attention and generated controversy. However, use
of a non-disease-specific concept like a DALY is
inevitable when you want to compare the burden of
morbidity (and its sequelae) of different diseases.
The controversy concentrates on two particular
aspects of the DALY methodology, one of which
we will look into - the weighting of life years by
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age; the other sensitive aspect is discounting of
future life years (12).
We must stress that we do not consider age-
weighting as such to be inappropriate or wrong; on
the contrary, we think it may certainly make sense,
depending on the purpose and circumstances. How-
ever, precisely because it is controversial it is of great
importance to apply it meticulously. One weak point
in the methodology as reported by Murray et al. is
that the age-weighting eventually produces a differ-
ent result from what might be expected from the age-
weight function. To illustrate this, we will first briefly
describe the DALY methodology, and then apply it
using a life-table.
The DALY methodology
The methodology assesses the impact on public
health, on both morbidity and mortality, of various
packages of health care that might be provided. Most
health care measures are disease-specific interven-
tions, either preventive or therapeutic, and this
makes it imperative to examine the effects of inter-
ventions on a disease-specific level. To compare the
impact of the intervention between diseases or
health care packages it is necessary to have a non-
disease-specific common denominator.
The established common denominator used to
be mortality or mortality-based measures such as life
expectancy and "potential years of life lost" (PYLL).
Including morbidity in the public health impact
means adopting a non-disease-specific measure to
express the burden of diseases and their sequelae. To
express the combination of mortality and morbidity
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in a single measure it has become a (disputed)
standard to value one year lived in good health
by 1, and a year lived with less than good health
by a value between 0 and 1, depending on the
severity of the health problem. The years not lived
(lost to premature mortality) are assigned a value
of 0.
Given the disease- and age-specific mortalities,
the "expected years of life lost" (EYLL) due to mor-
tality can be estimated by multiplying the number of
disease-specific deaths for each age by the life ex-
pectancy at that age (the so called "local life expect-
ancy"), and then summing over all deaths. Years lost
due to morbidity can be estimated by multiplying the
years lived with disease by the value between 0 and
1, summing the thus-weighted years lived, and sub-
tracting this number from the total unweighted
number of years lived. The sum of the years lost due
to mortality and morbidity then gives the total bur-
den of this particular disease.
The DALY methodology follows this basic
scheme, while adding the following features of its
own.
* The objective of measuring the total burden of
disease from all the important diseases combined.
This requires making consistent estimates of the inci-
dence, prevalence and mortality of a great number of
diseases, a number large enough to represent the
major part of the population's health. Using an
incidence, prevalence and mortality model, the
researchers forced their estimates to be internally
consistent, and while undoubtedly some estimates
may be inaccurate (13), this is a major achievement.
* The use of one standard life-table worldwide, and
not different regional life-tables. Murray argues con-
vincingly that this is necessary to compare "like with
like", and not to value a death at a given age more in
a high life-expectancy country than in a low one (1).
* The use of disability weights. Six classes of disabil-
ity severity were distinguished; using expert panels it
was determined how many people with a certain
disease would as a consequence be disabled, and
how these were distributed over the six classes.
Needless to say, this procedure has some weak-
nesses, but in that respect the DALY is no exception
among procedures to obtain disability weights, or
equivalents such as QALYs (quality-adjusted life
years) and utilities (14, 15).
* The use of age-weights. Murray cites both eco-
nomic and social role arguments to justify valuing
lost years of life due to mortality and morbidity dif-
ferently by age. Intuitively most people will agree
that the death of a newborn or a 90-year-old, al-
though tragic, is less so than that of a 15-year-old.
The quantitative implementation of this notion is, on
the other hand, a matter of much controversy.
Murray proposes the following general formula
to weight life years by age:
Cxe- x
where C and fi are constants, x is age, and e is the
exponential. For C = 0.16243 and fi = 0.04 (the
values used in the study) the age-weight curve is as
depicted in Fig. 1.
* The discounting of future years. Although in
economics it goes without saying that future costs
and benefits should be discounted, it is not a
generally accepted concept in the health sector that
future years of life should be treated similarly.
In the end, Murray presents a rather daunting
general formula that calculates the DALYs lost,
combining the years lost due to mortality and
morbidity, the age weights, and the discounting (1).
Because the lost DALYs are calculated using this
general formula, the effects of each step made to get
the end result remain obscure. This is illustrated
below by taking a closer look at age-weighting and
its effects.
Which ages count for more?
The age-weight function, with the parameters as
mentioned above, specifies that the years lived be-
tween the ages of 9 and 54 have a weight greater than
unity, and the years outside this range will have a
Fig. 1. The age-weight function, Cxe-x, where x is the
age, e the exponential, C = 0.16243 and , = 0.04.
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Fig. 2. Age-specific life expectancies for Dutch
women, 1986-90. Unweighted values the years lived
by 1 for all ages, weighting is done using the curve of
Fig. 1, unweighted discounted and weighted discounted
use a discount rate of 3%.
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weight less than unity, with a weight of 0 at exact age
0 (newborns). If, for simplicity's sake, we ignore the
DALYs lost due to morbidity (i.e., the disability
weights) and consider only mortality, the next step is
to use the age-weighted life years to calculate the
age-specific life expectancies that are needed to de-
termine the EYLL. We carried this out using the
1986-90 life-table for Dutch women (16), and Fig. 2
shows the resulting age-weighted and unweighted
age-specific life expectancies.
The first thing to note is that the impact of
age-weighting is much less than Fig. 1 would suggest:
the weighted and unweighted curves are fairly close.
In particular, the rather dramatic zero weight for
newborns translates into an only minor downturn of
the weighted curve. This is because the EYLL of a
newborn reflects all the future life years the baby
could expect to live, all of which are weighted more
than zero.
Secondly, and importantly, the age range which
becomes accentuated due to weighting (the range
where the weighted curve is above the unweighted
one) has shifted from between 9 and 54 years to
between 0 and 27 years. This shift towards younger
age becomes intuitive when one considers, for
example, a woman of 40 years, with a life expectancy
of 41 years. According to Fig. 1, 14 of those expected
years will receive a Weight greater than unity, and the
remaining 27 years a weight less than unity, yielding
an average weight of less than unity. Only when,
going towards younger ages, the number of expected
life years with a weight greater than 1 becomes large
enough to counterbalance the number with a weight
of less than 1 (for this life-table, at age 27, when
life expectancy is about 54 years), the weighted
curve will get above the unweighted one. While
the calculation is correct, this result may come as
something of a surprise.
Fig. 2 also shows the age-specific life expec-
tancies with future years discounted, both with and
without age-weighting. It is apparent that the impact
of discounting, even at such a slight rate as 3%, is
much larger than the age-weighting. The curve
labelled "weighted discounted" is the familiar,
"DALYs lost due to death" curve (1). The discount-
ing of future years partly redresses the shift towards
younger ages: the discounted age-weighted curve is
above the discounted unweighted curve in the range
0-38 years. This is because the discounting mostly
affects the life years lived at a higher age, years
which are now more easily counterbalanced by the
more-than-unity weighted years of middle age.
Discussion
We have shown that the age-weight function empha-
sizes deaths in the age range 0-27 years, instead of
the range 9-54 years as suggested by Murray. The
same will happen for disability when the disability
weights are applied to the years lived: disability
between 0 and 27 years will be emphasized, and
outside that range played down. Adding discoun-
ting displaces the emphasized age range to 0-38
years, but, strictly speaking, this is of no consequence
because discounting is concerned with time prefer-
ence, and not with age. Since Murray's arguments for
age-weighting are, on the one hand, economic (pro-
ductive years count more), and on the other social
(with middle-aged years more important than the
extremes), we presume that the shift towards child-
hood and early adult years is unintended.
It has apparently been overlooked that express-
ing a death (or disability) as "expected years of life
lost" implies age-weighting as well: younger deaths
are emphasized. Thus, in the calculation of the
DALY, one age-weighting system emphasizing the
young is piled on top of another, which emphasizes
the middle-aged. The result is an even stronger em-
phasis on the young, and de-emphasis on the old,
than the EYLL generates itself. Whether this is ad-
vantageous or not is debatable (we think not), but
it is certainly different from what we were led to
expect.
Will our finding upset the results of the Global
Burden of Disease study? That is very unlikely,
given the rather small impact of the age-weight
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function on the age-specific life expectancies (see
Fig. 2). It might even be sensible to abandon the
age-weighting function altogether, because of the
disproportionally large attention it has received,
relative to its impact. If it is retained, on the other
hand, some rethinking seems appropriate. With the
age-weight function as it is now, Alice's reaction to
the Jabberwocky poem comes to mind: "Somehow
it seems to fill my head with ideas - only I don't
exactly know what they are!" (17).
Resume
Les DALY et la ponderation par l'age
Dan les etudes realis6es pour le Rapport sur le
d6veloppement dans le monde 1993, Investir dans
la Sant6, Murray et ses collaborateurs ont mis au
point et applique plusieurs concepts nouveaux,
dont l'un les DALY (disability adjusted life years ou
annees de vie corrig6es de l'incapacite) a suscite
attention et controverse, situation inevitable dans
la mesure ou les comparaisons d'une pathologie
a I'autre tiennent compte non seulement de la
mortalite prematuree imputable a ces affections,
mais aussi de la morbidit6 et de ses sequelles. Le
present article envisage un aspect particulier de la
methode des DALY a savoir la ponderation des
annees de vie par l'age.
Murray cite les arguments tant 6conomiques
que sociaux pour justifier l'6valuation differentielle
en fonction de l'age des ann6es de vie perdues du
fait de la mortalite et de la morbidit6. Presque tout le
monde s'accorde intuitivement sur le fait que la
mort d'un nourrisson et celle d'une personne de 90
ans, aussi tragiques soient-elles, sont moindres
que celle d'un jeune de 15 ans. Pour mettre en
ceuvre quantitativement ce concept, Murray pro-
pose une formule generale pour pond6rer les
ann6es de vie en fonction de I'age. D'apres cette
fonction poids de l'age les annees v6cues entre 9 et
54 ans ont un poids sup6rieur a l'unite, les ann6es
se situant a l'exterieur de l'intervalle ayant un poids
inf6rieur a l'unit6 et le poids 6tant de 0 a l'age 0
(nouveau - n6). Si l'on ne considere que les DALY
perdues en raison de la mortalit6, 1'etape suivante
consiste a utiliser les annees de vie ponderees sur
l'age pour calculer l'esperance de vie par age,
necessaire pour determiner les annees de vie
attendues perdues (expected years of life lost ou
EYLL). C'est ce que nous avons fait avec les
courbes de survie des femmes n6erlandaises pour
1986-1990, d'ou nous avons tire l'esperance de vie
par age, pond6ree et non ponderee. On notera tout
d'abord, que l'impact de la ponderation sur l'age est
bien inf6rieur a ce que l'on pouvait penser: les
courbes avec ponderation et sans pond6ration sont
trbs proches. On remarque ensuite que la tranche
d'age qui devient la plus importante en raison de
la ponderation (la tranche ou la courbe avec
ponderation se situe au dessus de la courbe sans
pond6ration) et passee de 9 et 54 ans a 0 et 27 ans.
En ne tenant pas compte des annees futures, la
tranche d'age devient alors 0 a 38 ans.
L'orsqu'on calcule les DALY, un systeme de
ponderation (EYLL) qui met en valeur la jeunesse
s'ajoute a I'autre, ce qui donne de l'importance a
l'age moyen, et a pour resultat d'accentuer davan-
tage l'importance de la jeunesse - et de faire
perdre de l'importance aux personnes agees- que
les EYLL ne le font par elles-meme. La question de
savoir si c'est ou non une bonne chose (nous
estimons qu'elle est mauvaise) est controvers6e,
mais ce qui est certain c'est que le resultat obtenu
est different du resultat attendu. 11 n'est guere
probable que nos observations perturbent les
resultats de 1'6tude sur le poids de la morbidite
dans le monde, vu l'influence asssez faible
qu'exerce la fonction poids de l'age sur l'esperance
de vie par age. Toutefois, il serait peut-etre justifi6
d'abandonner completement la fonction poids de
l'age ou de repenser ses propri6t6s.
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